Isabelle Fromantin | CEpiA - Clinical Epidemiology and Ageing

Isabelle Fromantin

InfirmièrePhD

Enseignants chercheurs

01 44 32 44 28

http://www.kdog.fr/

Description

Infirmière, PhD, expert Plaies et Cicatrisation

Unité Plaies Cicatrisation et Recherche, Institut Curie, 26 rue d’Ulm, 75005 Paris

Publications

2021

Nicodème M, Dureau S, Chéron M, Kriegel I, Trenchand M, Bauër P, Fromantin I. Frequency and Management of Hemorrhagic Malignant Wounds: A Retrospective, Single-Center, Observational Study. J Pain Symptom Manage. 2021;62(1):134-140.
Nicodème M, Chéron M, Labedade É, Fromantin I, Lefort H. [Management of patients with haemorrhage malignant wounds]. Rev Infirm. 2021;70(273):27-30.
Segaux L, Broussier A, Oubaya N, Leissing-Desprez C, Laurent M, Naga H, Fromantin I, David J-P, Bastuji-Garin S. Several frailty parameters highly prevalent in middle age (50-65) are independent predictors of adverse events. Sci Rep. 2021;11(1):8774.
Broussier A, David JPhilippe, Kharoubi M, Oghina S, Segaux L, Teiger E, Laurent M, Fromantin I, Bastuji-Garin S, Damy T. Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg. J Clin Med. 2021;10(15).
Rollot-Trad F, Chéron M, Bonhomme S, Fromantin I, Engels C. [Needs and feelings of caregivers in oncogeriatrics, usefulness of a serious game]. Soins Gerontol. 2021;26(152):31-36.

2020

Leissing-Desprez C, Thomas E, Segaux L, Broussier A, Oubaya N, Marie-Nelly N, Laurent M, de Langavant LCleret, Fromantin I, David J-P, Bastuji-Garin S. Understated Cognitive Impairment Assessed with the Clock-Drawing Test in Community-Dwelling Individuals Aged ≥50 Years. J Am Med Dir Assoc. 2020;21(11):1658-1664.
Fromantin I, Canoui-Poitrine F, Engels C. [Meaning, research and knowledge]. Rev Infirm. 2020;69(265):22-24.
Engels C, Boutin E, Boussely F, Bourgeon-Ghittori I, Couturier B, Fromantin I, Lafuente-Lafuente C, Canoui-Poitrine F. Use of Evidence-Based Practice Among Healthcare Professionals After the Implementation of a New Competency-Based Curriculum. Worldviews Evid Based Nurs. 2020;17(6):427-436.

2019

Badois N, Bauër P, Chéron M, Hoffmann C, Nicodème M, Choussy O, Lesnik M, Poitrine FCanoui, Fromantin I. Acellular fish skin matrix on thin-skin graft donor sites: a preliminary study. J Wound Care. 2019;28(9):624-628.
Thuleau A, Gilbert C, Bauër P, Alran S, Fourchotte V, Guillot E, Vincent-Salomon A, Kerihuel J-C, Dugay J, Semetey V, Kriegel I, Fromantin I. A New Transcutaneous Method for Breast Cancer Detection with Dogs. Oncology. 2019;96(2):110-113.
Segaux L, Oubaya N, Broussier A, Baude M, Canoui-Poitrine F, Naga H, Laurent M, Leissing-Desprez C, Audureau E, Ferrat E, Chailloleau C, Fromantin I, David J-P, Bastuji-Garin S. Identification of five frailty profiles in community-dwelling individuals aged 50-75: A latent class analysis of the SUCCEED survey data. Maturitas. 2019;127:1-11.

2018

Thuleau A, Dugay J, Dacremont C, Jemmali Z, Elard J, De Ricke Y, Cassoux N, Watson S, Escande M-C, Fromantin I. Volatile Organic Compounds of Malignant Breast Cancer Wounds: Identification and Odors. Wounds. 2018;30(11):337–344.

2016

David J-P, Ferrat E, Parisot J, Naga H, Lakroun S, Menasria F, Saddedine S, Natella P-A, Paillaud E, Fromantin I, Bastuji-Garin S. White Matter Lesions: Prevalence and Clinical Phenotype in Asymptomatic Individuals Aged ≥50 Years. Dement Geriatr Cogn Disord. 2016;42(3-4):159-168.

2015

Bazire L, Fromantin I, Diallo A, de la Lande B, Pernin V, Dendale R, Fourquet A, Savignoni A, Kirova YM. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial. Radiother Oncol. 2015;117(2):229-33.

2014

Fromantin I, Watson S, Baffie A, Rivat A, Falcou M-C, Kriegel I, Ingenior Yde Rycke. A prospective, descriptive cohort study of malignant wound characteristics and wound care strategies in patients with breast cancer. Ostomy Wound Manage. 2014;60(6):38-48.

2013

Fromantin I, Seyer D, Watson S, Rollot F, Elard J, Escande MChristine, De Rycke Y, Kriegel I, Garde VLarreta. Bacterial floras and biofilms of malignant wounds associated with breast cancers. J Clin Microbiol. 2013;51(10):3368-73.

2012

Arzt H, Fromantin I, Ribinik P, Barrois B, Colin D, Michel J-M, Passadori Y. Which medical device and/or which local treatment are to be used, as of 2012, in patients with infected pressure sore? Developing French guidelines for clinical practice. Ann Phys Rehabil Med. 2012;55(7):498-507.

2011

Cottu PH, Fourchotte V, Vincent-Salomon A, Kriegel I, Fromantin I. Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy. J Wound Care. 2011;20(9):403-4, 406, 408 passim.